Cutibacterium (formerly Propionibacterium) acnes clavicular infection.

Cutibacterium (formerly Propionibacterium) acnes13, 16 is a slow growing, gram-positive bacteria that is naturally found in higher concentrations as skin flora on the chest and back, as well as in other areas with greater numbers of hair follicles.25, 37 Most of the reported cases of C. acnes shoulder girdle infection follow arthroplasty surgery,18, 20, 26, 27, 32, 35 which then often requires debridement, administration of intravenous antibiotics, and surgical revision of the implanted device.12, 15, 21, 28-30 In a recent study, 56% of 193 shoulder revisions had a positive culture, 70% of which grew C. acnes.30 Despite the relatively common presumed association of C. acnes humeral osteomyelitis with prosthetic infection, infection of the scapula or clavicle secondary to C. acnes is rare.4, 23, 36 Osteomyelitis of the clavicle involving any organism is also an uncommon event that can arise spontaneously via presumed hematogenous spread, or secondary to open fractures or internal fixation.6, 33 The most commonly found organism in clavicular osteomyelitis is Staphylococcus aureus.9 We here report two cases of clavicular infection secondary to C. acnes that were not associated with implants

Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: Potential implications according to the tumor resection status

Conventional therapy of primary bone tumors includes surgical excision with wide resection, which leads to physical and aesthetic defects. For reconstruction of bone and joints, allografts can be supplemented with mesenchymal stem cells (MSCs). Similarly, adipose tissue transfer (ATT) is supplemented with adipose-derived stem cells (ADSCs) to improve the efficient grafting in the correction of soft tissue defects. MSC-like cells may also be used in tumor-targeted cell therapy. However, MSC may have adverse effects on sarcoma development. In the present study, human ADSCs, MSCs and pre-osteoclasts were co-injected with human MNNG-HOS osteosarcoma cells in immunodeficient mice. ADSCs and MSCs, but not the osteoclast precursors, accelerated the local proliferation of MNNG-HOS osteosarcoma cells. However, the osteolysis and the metastasis process were not exacerbated by ADSCs, MSCs, or pre-osteoclasts. In vitro proliferation of MNNG-HOS and Saos-2 osteosarcoma cells was increased up to 2-fold in the presence of ADSC-conditioned medium. In contrast, ADSC-conditioned medium did not change the dormant, quiescent state of osteosarcoma cells cultured in oncospheres. Due to the enhancing effect of ADSCs/MSCs on in vivo/in vitro proliferation of osteosarcoma cells, MSCs may not be good candidates for osteosarcoma-targeted cell therapy. Although conditioned medium of ADSCs accelerated the cell cycle of proliferating osteosarcoma cells, it did not change the quiescent state of dormant osteosarcoma cells, indicating that ADSC-secreted factors may not be involved in the risk of local recurrence

Revised estimates of Taung’s brain size growth

Cranial capacity, a proxy for the volume of the brain and associated cranial contents, is an important yardstick used to compare early hominin species because increasing brain size is a key characteristic of our lineage. In 1925, Raymond Dart claimed that a natural endocast found at the Buxton Limeworks near Taung, South Africa (which he named Australopithecus africanus), showed signs of neural reorganisation, but its juvenile status complicated comparison to other hominoid species. In an attempt to put its brain size and reorganisation into a comparative context, subsequent researchers have tried to estimate Taung’s adult cranial capacity by comparison to coarse-grained hominoid growth data. In this study, we simulated brain growth in A. africanus using asymptotic growth models in known-age mountain gorillas, chimpanzees and modern humans, and show that, at just under 4 years old, Taung’s brain had already finished or nearly finished growing according to hominoid developmental schedules. Percentage-growth remaining estimates are lower here than in previous studies using cross-sectional ontogenetic samples of unknown chronological age. Our new adult estimates (between 404 cm3 and 430 cm3 overall and 405–406 cm3 for chimpanzee models) are smaller than previous estimates with a ‘starting’ cranial capacity of 404 cm3, supporting the hypothesis that Taung’s adult brain size would have fallen toward the lower end of the A. africanus range of variation and strengthening the case that Taung was female. Significance: This is one of several recent studies to show that brain growth is completed in African apes and humans earlier than previously appreciated. New adult cranial capacity estimates for Taung are lower than previous estimates, supporting the hypothesis that Taung was female. Cessation of brain growth in hominoids at earlier ages than previously reported suggests that adult cranial capacities for hominin juvenile specimens have been overestimated. Open data set: http://dx.doi.org/10.17632/wyfvwd4s2